Published in Malar J on December 21, 2012
Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc Natl Acad Sci U S A (2015) 1.13
Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens. J Infect Dis (2014) 1.07
Decline in childhood iron deficiency after interruption of malaria transmission in highland Kenya. Am J Clin Nutr (2014) 0.81
Multiple comparisons analysis of serological data from an area of low Plasmodium falciparum transmission. Malar J (2015) 0.79
Serological markers to measure recent changes in malaria at population level in Cambodia. Malar J (2016) 0.78
Protection of Malian children from clinical malaria is associated with recognition of multiple antigens. Malar J (2015) 0.77
Decrease in Numbers of Naive and Resting B Cells in HIV-Infected Kenyan Adults Leads to a Proportional Increase in Total and Plasmodium falciparum-Specific Atypical Memory B Cells. J Immunol (2017) 0.75
The Statistical Value of Raw Fluorescence Signal in Luminex xMAP Based Multiplex Immunoassays. Sci Rep (2016) 0.75
Multi-epitope chimeric antigen used as a serological marker to estimate Plasmodium falciparum transmission intensity in the border area of China-Myanmar. Infect Dis Poverty (2016) 0.75
Multiplexed particle-based flow cytometric assays. J Immunol Methods (2000) 5.09
Suppression of non-specific binding in serological Luminex assays. J Immunol Methods (2005) 2.96
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A (2010) 2.90
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial. Lancet Infect Dis (2011) 2.79
IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J (2007) 2.30
Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis (2010) 1.79
Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria. J Infect Dis (2000) 1.76
Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes. J Immunol Methods (2004) 1.74
Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J Immunol (1994) 1.72
Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection. Am J Trop Med Hyg (2005) 1.70
Sequential, ordered acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 domains. J Immunol (2009) 1.66
Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens. Clin Vaccine Immunol (2006) 1.55
Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology. J Immunol Methods (2005) 1.48
Longevity of the immune response and memory to blood-stage malaria infection. Curr Top Microbiol Immunol (2005) 1.36
Hierarchical, domain type-specific acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 in Tanzanian children. Infect Immun (2010) 1.19
Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission. Infect Immun (2008) 1.17
Schistosomiasis coinfection in children influences acquired immune response against Plasmodium falciparum malaria antigens. PLoS One (2010) 1.17
Clinical manifestations of severe malaria in the highlands of southwestern Uganda. Am J Trop Med Hyg (2005) 1.13
A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens. Malar J (2010) 1.11
Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection. Clin Exp Immunol (2009) 1.10
Cytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmission. Malar J (2005) 1.10
Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity. Infect Immun (2001) 1.10
Measuring immunoglobulin g antibodies to tetanus toxin, diphtheria toxin, and pertussis toxin with single-antigen enzyme-linked immunosorbent assays and a bead-based multiplex assay. Clin Vaccine Immunol (2008) 1.03
Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults. Malar J (2009) 1.00
Assessing the incidence of infection with Plasmodium falciparum among international travelers. Am J Trop Med Hyg (1998) 1.00
Development of a multiplexed bead-based immunoassay for the simultaneous detection of antibodies to 17 pneumococcal proteins. Eur J Clin Microbiol Infect Dis (2010) 0.98
Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania. BMC Infect Dis (2010) 0.92
Evaluation of the naturally acquired antibody immune response to the Pv200L N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon Region of Brazil. Am J Trop Med Hyg (2011) 0.90
Analysis of antigen-specific antibodies and their isotypes in experimental malaria. Cytometry A (2007) 0.87
A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum. Vet Immunol Immunopathol (2010) 0.85
Multiplex microbead measurements for the characterization of cat and ragweed allergen extracts. Ann Allergy Asthma Immunol (2010) 0.84
Humoral responses to defined malaria antigens in children living since birth under insecticide treated curtains in Burkina Faso. Acta Trop (2003) 0.81
Clinical and epidemiological characteristics of imported infectious diseases in Spanish travelers. J Travel Med (2010) 0.80
A microsphere-based duplex competitive immunoassay for the simultaneous measurements of aldosterone and testosterone in small sample volumes: validation in human and mouse plasma. Steroids (2010) 0.80
Rapid bead-based immunoassay for measurement of mannose-binding lectin. Scand J Immunol (2009) 0.79
Shift in epitope dominance of IgM and IgG responses to Plasmodium falciparum MSP1 block 4. Malar J (2010) 0.76
Malaria hotspot areas in a highland Kenya site are consistent in epidemic and non-epidemic years and are associated with ecological factors. Malar J (2006) 2.65
Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics (2007) 2.47
Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol (2005) 2.44
Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. J Infect Dis (2010) 2.19
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res (2010) 1.98
Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J Infect Dis (2011) 1.98
Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One (2009) 1.93
Low prevalence of Plasmodium falciparum infection among asymptomatic individuals in a highland area of Kenya. Trans R Soc Trop Med Hyg (2005) 1.73
Topography-derived wetness indices are associated with household-level malaria risk in two communities in the western Kenyan highlands. Malar J (2008) 1.70
Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg (2008) 1.69
Local topographic wetness indices predict household malaria risk better than land-use and land-cover in the western Kenya highlands. Malar J (2010) 1.45
Microscopy underestimates the frequency of Plasmodium falciparum infection in symptomatic individuals in a low transmission highland area. Am J Trop Med Hyg (2008) 1.44
Inpatient mortality in children with clinically diagnosed malaria as compared with microscopically confirmed malaria. Pediatr Infect Dis J (2008) 1.33
Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA. Infect Immun (2008) 1.29
Wash durability and optimal drying regimen of four brands of long-lasting insecticide-treated nets after repeated washing under tropical conditions. Malar J (2010) 1.28
Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria. Infect Immun (2004) 1.27
Socioeconomic predictors of cognition in Ugandan children: implications for community interventions. PLoS One (2009) 1.25
Immediate neuropsychological and behavioral benefits of computerized cognitive rehabilitation in Ugandan pediatric cerebral malaria survivors. J Dev Behav Pediatr (2009) 1.23
Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission. Infect Immun (2008) 1.17
Environmental, socio-demographic and behavioural determinants of malaria risk in the western Kenyan highlands: a case-control study. Trop Med Int Health (2009) 1.16
Clinical manifestations of severe malaria in the highlands of southwestern Uganda. Am J Trop Med Hyg (2005) 1.13
Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease. Cytokine (2008) 1.12
Malaria treatment-seeking behaviour and recovery from malaria in a highland area of Kenya. Malar J (2008) 1.10
Use of a three-band HRP2/pLDH combination rapid diagnostic test increases diagnostic specificity for falciparum malaria in Ugandan children. Malar J (2014) 1.07
Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial. Trials (2011) 1.06
The effect of repeated washing of long-lasting insecticide-treated nets (LLINs) on the feeding success and survival rates of Anopheles gambiae. Malar J (2010) 1.03
Hepatitis a screening for internationally adopted children from hepatitis A endemic countries. Clin Pediatr (Phila) (2013) 1.02
Rehabilitation for cognitive impairments after cerebral malaria in African children: strategies and limitations. Trop Med Int Health (2006) 1.01
Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen-1 and thrombospondin-related adhesive protein in residents of a malaria holoendemic area. Am J Trop Med Hyg (2006) 1.01
Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria. Pediatr Infect Dis J (2011) 1.01
Malaria with neurological involvement in Ugandan children: effect on cognitive ability, academic achievement and behaviour. Malar J (2011) 1.00
Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1. PLoS One (2011) 1.00
TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria. Am J Trop Med Hyg (2010) 1.00
Antibodies to Plasmodium falciparum antigens vary by age and antigen in children in a malaria-holoendemic area of Kenya. Pediatr Infect Dis J (2005) 0.99
Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites. J Infect Dis (2013) 0.99
Reliability of the Luganda version of the Child Behaviour Checklist in measuring behavioural problems after cerebral malaria. Child Adolesc Psychiatry Ment Health (2009) 0.96
Slow Clearance of Plasmodium falciparum in Severe Pediatric Malaria, Uganda, 2011-2013. Emerg Infect Dis (2015) 0.94
Development of a competency-based curriculum in global child health. Acad Med (2011) 0.92
Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines. Proc Biol Sci (2010) 0.92
Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris. Malar J (2009) 0.91
Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and thrombospondin-related adhesive protein immunodominant epitopes in a highland population from Western Kenya. Am J Trop Med Hyg (2009) 0.89
Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale. Med Hypotheses (2011) 0.89
Development of clinical immunity to malaria in highland areas of low and unstable transmission. Am J Trop Med Hyg (2012) 0.89
Cognition, behaviour and academic skills after cognitive rehabilitation in Ugandan children surviving severe malaria: a randomised trial. BMC Neurol (2011) 0.88
The association between cognition and academic performance in Ugandan children surviving malaria with neurological involvement. PLoS One (2013) 0.88
Changes in B Cell Populations and Merozoite Surface Protein-1-Specific Memory B Cell Responses after Prolonged Absence of Detectable P. falciparum Infection. PLoS One (2013) 0.85
Asymptomatic Malaria and Other Infections in Children Adopted from Ethiopia, United States, 2006-2011. Emerg Infect Dis (2015) 0.85
Sensitivity of fever for diagnosis of clinical malaria in a Kenyan area of unstable, low malaria transmission. Malar J (2014) 0.84
Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens. PLoS One (2012) 0.84
Essential factors for the development of a residency global health track. Clin Pediatr (Phila) (2012) 0.84
Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents. Expert Rev Anti Infect Ther (2012) 0.83
Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial. JMIR Res Protoc (2016) 0.83
Seizure activity and neurological sequelae in Ugandan children who have survived an episode of cerebral malaria. Afr Health Sci (2009) 0.83
Toll-like receptor polymorphisms and cerebral malaria: TLR2 Δ22 polymorphism is associated with protection from cerebral malaria in a case control study. Malar J (2012) 0.82
A family cluster of five cases of group A streptococcal pneumonia. Pediatrics (2003) 0.82
Absence of Smad3 induces neutrophil migration after cutaneous irradiation: possible contribution to subsequent radioprotection. Am J Pathol (2008) 0.82
Performance of point-of-care diagnostics for glucose, lactate, and hemoglobin in the management of severe malaria in a resource-constrained hospital in Uganda. Am J Trop Med Hyg (2014) 0.81
Decreased prevalence of anemia in highland areas of low malaria transmission after a 1-year interruption of transmission. Clin Infect Dis (2011) 0.81
Infections in internationally adopted children. Pediatr Clin North Am (2013) 0.81
Accurate diagnosis of cerebral malaria: a role for parasite histidine-rich protein 2? J Infect Dis (2012) 0.78
Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals. Malar J (2009) 0.77
Thrombocytopenia May Mediate Disease Severity in Plasmodium falciparum Malaria Through Reduced Transforming Growth Factor Beta-1 Regulation of Proinflammatory and Anti-inflammatory Cytokines. Pediatr Infect Dis J (2015) 0.76
The revolution in molecular biology leads to new understanding of the clinical expression of immunodeficiencies. J Pediatr (2003) 0.75
Diagnosing latent tuberculosis in international adoptees remains challenging. J Pediatr (2011) 0.75